Medtech Industry’s Wishlist For MHRA’s New UK Regulatory Structure

Convergence with EU regulation, enhanced patient safety and speedy delivery of innovation preoccupy UK medtechs going into 2022

alamy

More from Regulation

More from Policy & Regulation